PortfoliosLab logoPortfoliosLab logo
argenx SE (ARGX)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
NL0010832176
IPO Date
May 18, 2017

Highlights

Market Cap
$48.34B
Enterprise Value
$44.94B
EPS (TTM)
$32.69
PE Ratio
22.34
PEG Ratio
0.43
Total Revenue (TTM)
$5.49B
Gross Profit (TTM)
$4.38B
EBITDA (TTM)
$1.50B
Year Range
$510.06 - $934.62
Target Price
$1,026.71
ROA (TTM)
24.82%
ROE (TTM)
29.43%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in argenx SE, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

argenx SE (ARGX) has returned -13.16% so far this year and 23.38% over the past 12 months.


argenx SE

1D
3.68%
1M
-4.78%
YTD
-13.16%
6M
-0.99%
1Y
23.38%
3Y*
25.15%
5Y*
20.93%
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since May 18, 2017, ARGX's average daily return is +0.20%, while the average monthly return is +4.13%. At this rate, your investment would double in approximately 1.4 years.

Historically, 58% of months were positive and 42% were negative. The best month was Dec 2017 with a return of +97.2%, while the worst month was Jan 2022 at -23.1%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 5 months.

On a daily basis, ARGX closed higher 50% of trading days. The best single day was Dec 11, 2017 with a return of +78.9%, while the worst single day was Dec 20, 2023 at -25.1%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-0.05%-8.75%-4.78%-13.16%
20256.53%-4.65%-5.25%9.00%-11.14%-3.84%21.61%6.25%3.56%10.97%11.42%-7.79%36.74%
20240.02%-0.13%3.61%-4.63%-1.19%15.91%19.96%0.28%4.79%8.16%5.16%-0.25%61.66%
20230.90%-4.25%1.79%4.11%0.21%0.26%29.44%-0.39%-2.16%-4.49%-4.04%-15.57%0.42%
2022-23.11%6.85%9.59%-8.88%7.65%22.50%-3.87%3.75%-6.57%9.88%2.59%-4.81%8.18%
2021-0.36%12.85%-16.72%4.11%-2.69%7.91%1.12%8.73%-8.77%-0.01%-7.53%25.42%19.08%

Benchmark Metrics

argenx SE has an annualized alpha of 50.69%, beta of 0.73, and R² of 0.07 versus S&P 500 Index. Calculated based on daily prices since May 19, 2017.

  • This stock captured 200.04% of S&P 500 Index gains but only 60.98% of its losses — a favorable profile for investors.
  • R² of 0.07 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
50.69%
Beta
0.73
0.07
Upside Capture
200.04%
Downside Capture
60.98%

Return for Risk

Risk / Return Rank

ARGX ranks 61 for risk / return — better than 61% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


ARGX Risk / Return Rank: 6161
Overall Rank
ARGX Sharpe Ratio Rank: 6565
Sharpe Ratio Rank
ARGX Sortino Ratio Rank: 6060
Sortino Ratio Rank
ARGX Omega Ratio Rank: 5959
Omega Ratio Rank
ARGX Calmar Ratio Rank: 5959
Calmar Ratio Rank
ARGX Martin Ratio Rank: 6161
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for argenx SE (ARGX) and compare them to a chosen benchmark (S&P 500 Index).


ARGXBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.71

0.90

-0.19

Sortino ratio

Return per unit of downside risk

1.19

1.39

-0.19

Omega ratio

Gain probability vs. loss probability

1.16

1.21

-0.06

Calmar ratio

Return relative to maximum drawdown

0.84

1.40

-0.56

Martin ratio

Return relative to average drawdown

2.17

6.61

-4.44

Explore ARGX risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


argenx SE doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the argenx SE. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the argenx SE was 38.20%, occurring on Dec 20, 2023. Recovery took 177 trading sessions.

The current argenx SE drawdown is 21.45%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-38.2%Jul 24, 2023106Dec 20, 2023177Sep 5, 2024283
-36.29%Jun 13, 201884Oct 10, 201819Nov 6, 2018103
-34.13%Jan 10, 202045Mar 16, 202049May 26, 202094
-33.09%Feb 12, 2021242Jan 27, 2022108Jul 5, 2022350
-29.18%Jul 19, 201957Oct 8, 201940Dec 4, 201997

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of argenx SE over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how argenx SE is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for ARGX, comparing it with other companies in the Biotechnology industry. Currently, ARGX has a P/E ratio of 22.3. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for ARGX compared to other companies in the Biotechnology industry. ARGX currently has a PEG ratio of 0.4. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for ARGX relative to other companies in the Biotechnology industry. Currently, ARGX has a P/S ratio of 8.8. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for ARGX in comparison with other companies in the Biotechnology industry. Currently, ARGX has a P/B value of 6.6. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items